Suppr超能文献

血清胱抑素C作为肾功能的标志物。

Serum cystatin C as a marker of the renal function.

作者信息

Randers E, Kristensen J H, Erlandsen E J, Danielsen H

机构信息

Department of Internal Medicine, Viborg County Hospital, Denmark.

出版信息

Scand J Clin Lab Invest. 1998 Nov;58(7):585-92. doi: 10.1080/00365519850186210.

Abstract

The protease inhibitor cystatin C is a non-glycosylated low molecular weight protein (Mr=13359) which is produced by all nucleated cells at a constant rate, freely filtered by the renal glomeruli, and catabolized in the tubuli. The aim of the study was to elucidate the applicability of serum cystatin C as a marker of glomerular filtration rate (GFR) in patients with various kidney diseases with a wide range of renal function and in dialysis patients. Seventy-six patients with various kidney diseases (aged 20 to 79 years) and 61 dialysis patients (aged 21 to 82 years) were included. Serum cystatin C was measured by automated particle-enhanced immunoturbidimetry, serum and urine creatinine by an enzymatic method, and GFR by 99mTc-DTPA-clearance using a single plasma sample method. Serum cystatin C in patients with various kidney diseases was 1.90+/-0.98 mg/L (mean+/-SD) and in dialysis patients 7.14+/-1.91 mg/L. In the non-dialysis patients a linear relationship was found between 99mTc-DTPA-clearance and 1/serum cystatin C (r=0.91, p-value<0.0001), 1/serum creatinine (r=0.89, p-value<0.0001), and creatinine-clearance (r=0.88, p-value<0.0001). Comparison of the non-parametric ROC plots for serum cystatin C (area under the curve (AUC)=0.9665; SE=0.0169), serum creatinine (AUC=0.9554; SE=0.0205), and creatinine-clearance (AUC=0.9731; SE=0.0160) revealed no significant differences (p-values: 0.50, 0.78, and 0.49). In conclusion, cystatin C may be a likewise good marker of the GFR as serum creatinine and creatinine-clearance, cystatin C having the advantage being independent of gender and muscle mass.

摘要

蛋白酶抑制剂胱抑素C是一种非糖基化的低分子量蛋白质(分子量=13359),由所有有核细胞以恒定速率产生,经肾小球自由滤过,并在肾小管中被分解代谢。本研究的目的是阐明血清胱抑素C作为肾小球滤过率(GFR)标志物在肾功能范围广泛的各种肾脏疾病患者及透析患者中的适用性。研究纳入了76例各种肾脏疾病患者(年龄20至79岁)和61例透析患者(年龄21至82岁)。采用自动颗粒增强免疫比浊法测定血清胱抑素C,采用酶法测定血清和尿肌酐,并采用单样本血浆法通过99mTc-DTPA清除率测定GFR。各种肾脏疾病患者的血清胱抑素C为1.90±0.98mg/L(均值±标准差),透析患者为7.14±1.91mg/L。在非透析患者中,发现99mTc-DTPA清除率与1/血清胱抑素C(r=0.91,p值<0.0001)、1/血清肌酐(r=0.89,p值<0.0001)及肌酐清除率(r=0.88,p值<0.0001)之间存在线性关系。血清胱抑素C(曲线下面积(AUC)=0.9665;标准误=0.0169)、血清肌酐(AUC=0.9554;标准误=0.0205)和肌酐清除率(AUC=0.9731;标准误=0.0160)的非参数ROC曲线比较显示无显著差异(p值分别为0.50、0.78和0.49)。总之,胱抑素C可能与血清肌酐和肌酐清除率一样是良好的GFR标志物,胱抑素C的优势在于其不受性别和肌肉量的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验